In Vitro Delivery of PMOs in Myoblasts by Electroporation.

Remko Goossens, Annemieke Aartsma-Rus

Methods in molecular biology (Clifton, N.J.) 2022

filter terms:

Antisense oligonucleotides (AONs) are small synthetic molecules of therapeutic interest for a variety of human disease. Their ability to bind mRNA and affect its splicing gives AONs potential use for exon skipping therapies aimed at restoring the dystrophin transcript reading frame for Duchenne muscular dystrophy (DMD) patients. The neutrally charged phosphorodiamidate morpholino oligomers (PMOs) are a stable and relatively nontoxic AON modification. To assess exon skipping efficiency in vitro, it is important to deliver them to target cells. Here, we describe a method for the delivery of PMOs to myoblasts by electroporation. The described protocol for the Amaxa 4D X unit nucleofector system allows efficient processing of 16 samples in one nucleocuvette strip, aiding in high-throughput PMO efficacy screens. © 2022. The Author(s).

Citation

Remko Goossens, Annemieke Aartsma-Rus. In Vitro Delivery of PMOs in Myoblasts by Electroporation. Methods in molecular biology (Clifton, N.J.). 2022;2434:191-205